MM cells also constitutively produce, due to oncogene activation and/or genetic mutations, factors such as VEGF, basic fibroblast growth factor (bFGF), and matrix metalloproteinases (MMP)s that stimulate BM angiogenesis [34]. This evidence concerns the gene FGF2 and Miyoshi myopathy.